Naxitamab (anti-GD2) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers.Purity:>95% (SDS-PAGE&SEC)Endotoxin Level:< 1.0EU/mg.
Specifications and Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
- UPC:
- 51142301
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab170516-5mg
- CAS:
- 1879925-92-4
- Product Size:
- 5mg
akash.verma@cenmed.com
(732) 447-1115





